
Enterprise-level L4-L5 serialization and traceability software for pharmaceutical compliance with DSCSA, EU FMD, and global regulations.
OPTEL VerifyBrand is an enterprise-level L4-L5 serialization and traceability platform designed specifically for pharmaceutical manufacturers and supply chain stakeholders. The cloud-based SaaS solution manages serial number generation, event tracking, and regulatory reporting across global markets including the US (DSCSA), EU (FMD), China, India, Russia, and UAE.
The platform is built on GS1 EPCIS standards to avoid proprietary formats and vendor lock-in. VerifyBrand provides out-of-the-box connectivity with major serialization systems and integrates with existing ERP, MES, and WMS infrastructure via standard APIs. Key capabilities include automated aggregation from unit to case to pallet, real-time validation and exception handling, graphical serial number mapping, and secure downstream partner portal access.
OPTEL is the market leader in pharmaceutical serialization with 25.7% market share according to MarketsandMarkets. The company has 6,000+ systems installed worldwide, tracking 25 billion products annually. VerifyBrand customers include Pfizer, Johnson & Johnson, GSK, Teva, Sandoz, and Bayer.
VerifyBrand is purpose-built for pharmaceutical serialization compliance. The platform addresses DSCSA, EU FMD, and global pharmaceutical regulations including China NMPA, India Track and Trace, Russia Chestny ZNAK, and UAE Tatmeen requirements.
Cloud-based SaaS platform with SOC 2 Type II certification for data security. Built on GS1 EPCIS open standards to avoid proprietary formats and vendor lock-in. Multi-language user interface with automated workflow capabilities.
Provides out-of-the-box connectivity with major serialization systems and integrates with existing ERP, MES, and WMS infrastructure via standard REST APIs. Supports 5-level serialization architecture: L1-L2 (physical equipment and line control), L3 (plant-level management), L4-L5 (enterprise cloud platform for serial number generation and regulatory submissions).
Architecture allows flexible deployment with no requirement to replace existing infrastructure. Includes secure downstream partner portal for EPCIS data sharing.
Fixed-cost pricing model with transparent pricing and no hidden fees. Unlimited serial numbers included at no additional charge. Pricing includes full platform validation (IQ, OQ, Production IQ), document authoring (URS, CMO, 3PL integration), and optional managed services.
Cloud SaaS deployment with free upgrades included. No charges for optional tools. OPTEL provides single-vendor support.
24/7 SLA with 2-hour response time. Onboard training included. Most customers log fewer than one support ticket annually according to vendor.
Standard pharmaceutical serialization implementation: 12-16 weeks. Complex multi-tier implementations: 3-9 months. Expected performance impact during initial rollout: 5-7%, with recovery as operators gain proficiency.
Five-phase deployment approach: (1) Consultation and Site Readiness - infrastructure assessment, (2) Turnkey System Design - hardware/software integration, (3) Integration and Deployment - API-based MES/ERP connectivity, (4) Training and Validation - role-specific operator training with automated reports, (5) Ongoing Support - 24/7 global support with remote monitoring.
Implementation includes validation documentation (IQ, OQ, Production IQ), URS development, CMO and 3PL integration document authoring. Turnkey partner integration with dedicated account management.
PharmaSpotter assessment from published vendor and third-party sources. No user reviews are on file for this product.
Market leader with 25.7% share and largest installation base in pharmaceutical serialization. 6,000+ systems deployed globally tracking 25 billion products annually. 96% customer satisfaction rating for service. 35+ years of industry expertise since 1989. Fixed-cost pricing model with no hidden fees or charges for serial numbers. GS1 EPCIS-native architecture avoids proprietary lock-in. Single-vendor support model simplifies multi-site deployments. 24/7 support with 2-hour response SLA. Customer base includes Pfizer, J&J, GSK, Teva, Sandoz, Bayer. Certified B Corporation.
No G2 listing exists. A Capterra listing exists under the product name VerifyBrand but carries no user reviews - neither platform provides independent user feedback. Implementation timeline is 12-16 weeks for standard deployments, 3-9 months for complex multi-tier ones. Initial performance impact of 5-7% during rollout disclosed by vendor. Company is privately funded with ~$12.9M total funding, which may affect R&D investment capacity.
Share your experience with OPTEL VerifyBrand anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section